Advertisement
  • Reuters

    GSK faces whistleblower lawsuit over Zantac cancer risk

    GSK has been sued by an independent Connecticut laboratory that accused the drugmaker of defrauding the U.S. government and taxpayers by concealing cancer risks in Zantac, once a blockbuster heartburn drug. In a whistleblower complaint filed on Monday, Valisure said GSK violated the federal False Claims Act by hiding the risks for nearly four decades while Medicare, Medicaid and other health programs covered billions of dollars of prescriptions. The New Haven-based lab said its testing in 2019 revealed that Zantac, also known as ranitidine, could form a cancer-causing carcinogen known as NMDA and was therefore "unfit for human consumption."

  • BBC

    King and Queen visit Chelsea Flower Show

    The King visits the Chelsea Flower Show days after he is named the Royal Horticultural Society's patron.

  • Associated Press

    Philadelphia requires all full-time city employees to return to the office

    Philadelphia has mandated all city employees to return to their offices if employed full-time, as of July 15. Mayor Cherelle Parker made the announcement Monday, saying she wants to create a more visible and accessible government. The decision ends the city’s virtual work policy that was put in place in 2021 and essentially returns employees to pre-pandemic scheduling.